Effective August 1st, 2017, Government will increase verification fees on 37 selected medicines that can and are locally manufactured from 2% to 12%.
These include Amoxillin, Albendazole, Dextrose Infusion, Paracetamol, and Oral Rehydration Salts among others.
Junior Health Minister of State for Health Hon Sarah Opendi revealed Monday that the decision was made following the Ministry of Health and the National Drug Authority’s assessment of the domestic manufacturers’ capacity to sufficiently meet the demand for the 37 selected medicines.
Hon Opendi told press in Kampala that the increment in the verification fees is meant to discourage importation of locally manufactured drugs and also support the growth of the industry.
“Supporting domestic production of human, veterinary medicines and health care products will reduce reliance on imports and contribute towards national development aspirations of industrialization as provided for in the current vision 2040,” she said.
President Yoweri Museveni recently tasked the Ministry of Health to promote Local Pharmaceutical manufacturing and attract more pharmaceutical manufactures to set up industries in Uganda.
“This will not only promote access to safe, efficacious and quality medicines for our population, but create linkages to other sectors like packaging, construction and others. In addition, the presence of local manufacturing industries will also create jobs for the hundreds of jobless youth and ensure that Uganda is self-sustaining in terms of Pharmaceutical products,” reassured the minister.
“We have has also tasked the National Drug Authority to establish a rigorous post market surveillance system which will ensure that all the medicines on the market, both imported and locally manufactured are closely monitored for safety, efficacy and quality”.
In the Financial Year 2017/18, the Authority also plans to invest Uganda Shillings 2.7 Billion in equipping the National Quality Control Laboratory to detect all substandard and falsified medicines on the market.